Skip to content
healthcare.dev
Get a free key

NAPROXEN SODIUM

NDC 68210-4096, NAPROXEN SODIUM, tablet, film coated, extended release, from SPIRIT PHARMACEUTICALS,LLC.

Product NDC
68210-4096
Status
Listed
Labeler
SPIRIT PHARMACEUTICALS,LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA091353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68210-4096 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
68210-4096-168210409601365 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68210-4096-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68210-4096 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68210-4096 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68210-4096. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.